SFX by Ex Libris Inc.

Title:	The Costs and Cost-Effectiveness of Unrelated Donor Bone Marrow Transplantation for Chronic Phase Chronic Myelogenous Leukemia
Source:	Blood [0006-4971] Lee, Stephanie yr:1998

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Patenaude, Andrea F. "Psychological costs of bone marrow transplantation in children." American journal of orthopsychiatry 49.3 (1979): 409-422.
description	2.	Lee, S J J. "Unrelated donor bone marrow transplantation for chronic myelogenous leukemia: a decision analysis." Annals of internal medicine 127.12 (1997): 1080-8.
description	3.	Westerman, I L L. "A review of the costs, cost-effectiveness and third-party charges of bone marrow transplantation." Stem cells 14.3 (1996): 312-319.
description	4.	Sekeres, Michael W A. "A Decision analysis to determine the appropriate treatment for low-risk myelodysplastic syndromes." Cancer 109.6 (2007): 1125-32.
description	5.	Hurley, G. "Comparison of the efficacy and cost effectiveness of pre-emptive therapy as directed by CMV antigenemia and prophylaxis with ganciclovir in lung transplant recipients." The Journal of heart and lung transplantation 19.4 (2000): 355-9.
description	6.	Bevans, M. F., M.F. F. "Health-related quality of life in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation." Bone marrow transplantation 38.2 (2006): 101-109.
description	7.	Olsen KR, Kim R R. "Cost-effectiveness of surveillance programs for families at high and moderate risk of hereditary non-polyposis colorectal cancer." International journal of technology assessment in health care 23.1 (2007): 89-95.
description	8.	Cordonnier, C. "Do minitransplants have minicosts? A cost comparison between myeloablative and nonmyeloablative allogeneic stem cell transplant in patients with acute myeloid leukemia." Bone marrow transplantation 36.7 (2005): 649-654.
description	9.	Prosser, L A A. "Cost-effectiveness of cholesterol-lowering therapies according to selected patient characteristics." Annals of internal medicine 132.10 (2000): 769-79.
description	10.	Rogowski, W. "Genetic screening by DNA technology: a systematic review of health economic evidence." International journal of technology assessment in health care 22.3 (2006): 327-37.
description	11.	Goldman, L. "Comparing impact and cost-effectiveness of primary prevention strategies for lipid-lowering." Annals of internal medicine 150.4 (2009): 243-54.
description	12.	Golshayan, Tao A. "Efficacy of growth factors compared to other therapies for low-risk myelodysplastic syndromes." British journal of haematology 137.2 (2007): 125-32.
description	13.	"University of Texas publishes research in gynecologic cancer (Cost-effectiveness analysis of prevention strategies for gynecologic cancers in Lynch syndrome)." Women's health weekly. .
description	14.	Kurosawa, S. "A Markov decision analysis of allogeneic hematopoietic cell transplantation versus chemotherapy in patients with acute myeloid leukemia in first remission." Blood 117.7 (2011): 2113-2120.
description	15.	van der Post, J H J M S. "Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers." Journal of Medical Genetics 47.7 (2010): 464-470.
description	16.	Hampel, H. "Screening for the lynch syndrome." New England Journal of Medicine, The 352.18 (2005): 1851-5.
description	17.	Thompson, John A A. "Total body irradiation, etoposide, cyclophosphamide, and autologous peripheral blood stem-cell transplantation followed by randomization to therapy with interleukin-2 versus observation for patients with non-Hodgkin lymphoma: results of a phase 3 randomiz." Blood (2008): 4048-54.
description	18.	Watson, M. "Adverse impact of bone marrow transplantation on quality of life in acute myeloid leukaemia patients: analysis of the UK Medical Research Council AML 10 Trial." European journal of cancer 40.7 (2004): 971-8.
description	19.	Borie, F. "Cost-effectiveness of two follow-up strategies for curative resection of colorectal cancer: Comparative study using a Markov model." World journal of surgery 28.6 (2004): 563-569.
description	20.	Esperou, H. "Quality of life and socioeconomic aspects of hematopoietic cell transplantation." Current opinion in organ transplantation 10.1 (2005): 59-65.